PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33317858-8	2021	Treatment of 5 patients with recalcitrant GA with tofacitinib inhibited IFN-gamma and oncostatin M, as well as IL-15 and IL-21, activity and resulted in clinical and histologic disease remission in 3 patients and marked improvement in the other 2.	tofacitinib	50-61	oncostatin M	Homo sapiens	86-98	
23968543-6	2013	The JAK inhibitors CP-690,550 and INCB028050 both suppressed activation of JAK-1/-2/-3 and downstream STAT-1/-3/-5, as well as the expression levels of target proinflammatory genes (MCP-I, SAA1/2) in oncostatin-M (OSM)-stimulated rheumatoid synovial fibroblasts.	tofacitinib	19-25	oncostatin M	Homo sapiens	200-212	
29790294-10	2018	Tofacitinib inhibited the effect of oncostatin M (OSM) on interleukin-6 (IL-6) and monocyte chemotactic protein 1 and reversed the effects of OSM on RASF cellular metabolism.	tofacitinib	0-11	oncostatin M	Homo sapiens	36-48	
30984167-12	2019	Results: Tofacitinib and baricitinib decreased the IL-6 release of RASF stimulated with oncostatin M.	tofacitinib	9-20	oncostatin M	Homo sapiens	88-100